MedTrace Logo

Biometric and Biological Data for Diagnosis and Therapy of Pain Patients

NCT04835779 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2023-01-09

No results posted yet for this study

Summary

In order to meet the challenge of an unambiguous diagnosis and effective therapy of SFN or the prognosis of susceptibility to the development of SFN, this project aims to create a data basis on which software will be developed during the project. This software should later be able to combine (integrate) quantifiable biometric data collected from the patient (both objectively measured and patient reported parameters) with the results of biological analyses of the patient's own nerve cells from stem cells. We expect that the patient-specific combination and correlation of biometric and biological data can lead to a significant improvement in the diagnosis, prognosis and therapy of chronic pain. The initial data collection required for the development of such a software (Bio2Integrate) will be carried out in three different project parts: Bio2Watch, Bio2Patient and Bio2Cell

Conditions

  • Small Fiber Neuropathy

Sponsors & Collaborators

  • Grünenthal GmbH

    collaborator INDUSTRY

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Roman Rolke, Prof. Dr. · Universitätsklinikum Aachen, AöR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04835779 on ClinicalTrials.gov